Colonoscopy Clinical Trial
Official title:
A Trial of Segmental Stiffening Wires to Improve the Efficiency and Patient Tolerability of Colonoscopy
Verified date | October 2019 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will test the use of a new device called a segmental stiffening wire (SSW) in
colonoscopy to correct a problem called looping. Colonoscopy is the best test for detecting
early colon cancer and removing growths called polyps, which can become colon cancer.
Sometimes the flexible tube (colonoscope) used in the procedure loops at a certain point as
it advances through the colon, making it difficult to move further and causing the patient
pain from excessive stretching of the colon. The SSW is designed to prevent this by
stiffening the part of the tube that would otherwise form the loop.
Healthy subjects between 50 and 80 years of age and healthy subjects 40 years and older who
have a family history of colon cancer may be eligible for this study.
Participants undergo colonoscopy a day after self-administering a bowel cleansing
preparation. The first part of the procedure is done similarly to that of a flexible
sigmoidoscopy, and no sedation or pain medication is used. The colonoscope is inserted into
the rectum and advanced about one-third the length of the colon. Pain or discomfort should be
mild to moderate cramping and a feeling of having to move the bowels. The subject is asked to
score his or her pain level at this point using a standard pain scale. If there is pain, the
procedure is stopped and an x-ray is taken to determine if the colonoscope has looped. If it
has, the loop is undone and the SSW is used. Another x-ray is then taken to document that the
loop has been prevented with the SSW, and the procedure is completed as per standard medical
practice. Subjects are taken to the recovery area, informed of the test results and then
discharged home in the care of an accompanying adult.
Status | Completed |
Enrollment | 42 |
Est. completion date | September 21, 2016 |
Est. primary completion date | September 21, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
- INCLUSION CRITERIA: Colonoscopy is indicated based on well-established national guidelines. This includes volunteers age 50 or greater who are at average risk for colon cancer, and volunteers age 40 or greater who are at increased risk based on a personal history of colon polyps or a family history of colon polyps or cancer. Volunteer meets the criteria of Anesthesia Level 1 or 2. Volunteer agrees to undergo the study procedures. EXCLUSION CRITERIA: Ongoing psychiatric history including volunteers who have been hospitalized for psychiatric reasons, have missed significant number of days of work for psychiatric reasons, or who admit to suicidal ideations. Former or current history of alcohol or drug dependency. History of colonic resection. Pregnancy. Age greater than 80 or less than 40. Prior radiation to the abdomen or pelvis. American Society of Anesthesiologists Grade 3, 4, or 5. Allergy or other contraindications to midazolam or fentanyl. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Kahi CJ, Rex DK. Current and future trends in colorectal cancer screening. Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):137-44. Review. — View Citation
Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):389-94. — View Citation
Wu GH, Wang YM, Yen AM, Wong JM, Lai HC, Warwick J, Chen TH. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. BMC Cancer. 2006 May 24;6:136. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cecal Intubation Time | Cecal intubation time of colonoscopy with SSW, compared to without SSW | During colonoscopy, up to 60 minutes | |
Primary | Number of Participants Without Re-looping Among Those With Looping | Re-looping during the procedure that used SSW, this information only collected when using SSW | During the colonoscopy, up to 60 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04101097 -
Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
|
||
Completed |
NCT03247595 -
Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy
|
N/A | |
Completed |
NCT04214301 -
An Open-Label Preference Evaluation of BLI800
|
Phase 4 | |
Withdrawn |
NCT05754255 -
Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center
|
N/A | |
Recruiting |
NCT02484105 -
Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction
|
Phase 4 | |
Active, not recruiting |
NCT02264249 -
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
|
N/A | |
Terminated |
NCT01978509 -
The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies
|
N/A | |
Completed |
NCT01964417 -
The Comparative Study Between Bowel Preparation Method
|
Phase 3 | |
Recruiting |
NCT01685970 -
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
|
Phase 3 | |
Completed |
NCT01518790 -
Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children
|
N/A | |
Recruiting |
NCT00748293 -
Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet
|
N/A | |
Completed |
NCT00779649 -
MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial
|
Phase 4 | |
Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
Completed |
NCT00380497 -
Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children
|
Phase 4 | |
Recruiting |
NCT00160823 -
Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
|
Phase 3 | |
Completed |
NCT00314418 -
Patient Position and Impact on Colonoscopy Time
|
N/A | |
Completed |
NCT00390598 -
PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
|
Phase 2/Phase 3 | |
Completed |
NCT00209573 -
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
|
Phase 3 | |
Completed |
NCT00427089 -
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
|
Phase 3 | |
Completed |
NCT05823350 -
The Effect of Abdominal Massage on Pain and Distention After Colonoscopy
|
N/A |